JPRN-UMIN000041108
Completed
未知
Validation study on the effects on liver function and skin barrier function by intake of adlay - Validation study on the effects on liver function and skin barrier function by intake of adlay
ConditionsHealthy Adults
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Healthy Adults
- Sponsor
- Healthcare Systems Co., Ltd.
- Enrollment
- 70
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Persons who have chronic illness, receiving medication, have a serious disease history 2\.Persons who are allergic to the test food 3\.Persons who usually take a large amount of test food 4\.Persons whose ALT or AST is over 51 U/L at screening 5\.Persons whose gamma\-GTP is over 101 U/L at screening 6\.Persons whose habitually consume higher amount of alcohol (\>60g alcohol/day) 7\.Persons who have skin disease such as atopic dermatitis, urticaria, eczema and dermatitis. 8\.Persons who regularly use medicines, specified insurance foods, health foods, etc. that may affect liver function and skin function 9\.Persons who have participated in other tests within the first month before the start of the test, or those who intend to participate in another exam after consenting to this exam 10\.Persons who are pregnant, planning or hoping to be pregnant during the study period, breastfeeding 11\.Persons who were judged as inappropriate for subjects by the principal investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of the improving effects on liver function, status of fatigue, mood, and sleep after ingestion of the supplementHealthy adultJPRN-UMIN000044415EP Mediate Co., Ltd.44
Completed
Not Applicable
Examination of liver function improvement effect by administering a Ipragliflozin.DiabeticJPRN-UMIN000016198agasaki University Hospital100
Suspended
Not Applicable
Stratify methotrexate: a study to investigate the liver function of patients taking methotrexate, and risk-stratify them accordinglyiver fibrosisDigestive SystemHepatic fibrosisISRCTN14696018York Teaching Hospital NHS Foundation Trust2,000
Completed
Not Applicable
Evaluation for efficacy of liver function by ingestion of supplement containing plant derived extractiveHealthy subjectsJPRN-UMIN000027495TTC Co., Ltd.40
Completed
Phase 1
A Study to Understand How the Study Medicine (PF-07081532) is Processed in People With Liver DysfunctionHepatic ImpairmentHealthy VolunteersNCT05478603Pfizer24